• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

INFLIFE:SV

25.25 EUR 0.29 1.18%

As of 09:20:00 ET on 11/21/2014.

Snapshot for Infond Life (INFLIFE)

Year To Date: +28.26% 3-Month: +11.41% 3-Year: +26.63% 52-Week Range: 18.80 - 25.17
1-Month: +9.01% 1-Year: +29.13% 5-Year: +17.91% Beta vs SBITOP: 0.39

Mutual Fund Chart for INFLIFE

No chart data available.
  • INFLIFE:SV 25.25
  • 1M
  • 1Y
Interactive INFLIFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for INFLIFE

Infond Life is an open-end investment fund incorporated in Slovenia. The Fund's objective is to invest primarily in companies from healthcare sector. The Fund's objective is capital appreciation.

Inception Date: 06-04-2007 Telephone: 386-2-229-2080
Managers: BARBARA GACNIK
Web Site: www.infond.si

Fundamentals for INFLIFE

NAV (on 2014-11-21) 25.25
Assets (M) (on 2014-11-21) 28.03
Fund Leveraged N
Minimum Investment 12.00
Minimum Subsequent Investment -

Dividends for INFLIFE

No dividends reported

Fees & Expenses for INFLIFE

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.20

Top Fund Holdings for INFLIFE

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 13,490 1,205,714 4.630%
Johnson & Johnson 13,746 1,182,276 4.540%
Novartis AG 15,719 1,164,048 4.470%
Pfizer Inc 48,686 1,153,631 4.430%
Roche Holding AG 4,848 1,140,610 4.380%
Merck & Co Inc 19,543 903,634 3.470%
Amgen Inc 5,918 763,011 2.930%
Novo Nordisk A/S 19,357 697,908 2.680%
Actavis plc 3,549 687,491 2.640%
Sanofi 8,980 661,450 2.540%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil